Previous Article | Next Article 
Molecular and Cellular Biology, September 2000, p. 6390-6398, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Studies on the Candidate ATPase Domains
of Saccharomyces cerevisiae MutL
Phuoc T.
Tran and
R. Michael
Liskay*
Department of Molecular and Medical Genetics,
Oregon Health Sciences University, Portland, Oregon 97201
Received 21 March 2000/Returned for modification 4 May
2000/Accepted 7 June 2000
 |
ABSTRACT |
Saccharomyces cerevisiae MutL homologues Mlh1p and
Pms1p form a heterodimer, termed MutL
, that is required for DNA
mismatch repair after mismatch binding by MutS homologues. Recent
sequence and structural studies have placed the NH2 termini
of MutL homologues in a new family of ATPases. To address the
functional significance of this putative ATPase activity in MutL
, we
mutated conserved motifs for ATP hydrolysis and ATP binding in both
Mlh1p and Pms1p and found that these changes disrupted DNA mismatch
repair in vivo. Limited proteolysis with purified recombinant MutL
demonstrated that the NH2 terminus of MutL
undergoes
conformational changes in the presence of ATP and nonhydrolyzable ATP
analogs. Furthermore, two-hybrid analysis suggested that these
ATP-binding-induced conformational changes promote an interaction
between the NH2 termini of Mlh1p and Pms1p. Surprisingly,
analysis of specific mutants suggested differential requirements for
the ATPase motifs of Mlh1p and Pms1p during DNA mismatch repair. Taken
together, these results suggest that MutL
undergoes ATP-dependent
conformational changes that may serve to coordinate downstream events
during yeast DNA mismatch repair.
 |
INTRODUCTION |
The process of DNA mismatch repair
(MMR) has been the focus of intense study since human MMR gene
mutations were implicated in hereditary and sporadic forms of human
cancer (13, 21, 39, 52). A primary role of MMR is to correct
base-base mismatches and insertion-deletion loops (IDLs) resulting from
DNA replication, endogenous or exogenous sources of DNA damage, and
recombination (14, 36, 38, 43). In Escherichia
coli, where MMR has been reconstituted in vitro by using purified
proteins, a homodimer of MutS binds the mismatch, followed by the
formation of an ATP-binding-dependent ternary complex with a homodimer
of MutL. The latent endonuclease activity of MutH is stimulated by the
ATP-dependent MutS-MutL ternary complex to nick the undermethylated
strand at the nearest hemimethylated GATC site. After incision, UvrD
helicase and four exonucleases excise the nascent strand some distance
past the mismatch (68). The resultant single-strand gap (up
to 1 kb) is filled in by DNA polymerase III, and the nick is sealed by DNA ligase (43).
In the yeast Saccharomyces cerevisiae, the mutation
avoidance functions of MMR involve multiple MutS and MutL heterodimers with partially overlapping functions (36, 38). For example, a heterodimer of Msh2p and Msh6p, MutS
, appears to be involved primarily in correcting mismatches and +1 IDL heterologies (2, 3,
12, 19, 23, 32, 33, 37, 41, 42, 48, 64), whereas, an Msh2p-Msh3p
heterodimer, MutS
, functions in correction of IDLs with 1 to 14 bases (23, 37, 41, 49). The major MMR MutL activity,
MutL
, in yeast is a heterodimer of Mlh1p and Pms1p (27, 51, 58,
59). An additional yeast MutL activity, MutL
, comprised of
Mlh1p and Mlh3p, appears to act in conjunction with MutS
to correct
a small fraction of IDLs (22).
An important clue to a possible biochemical activity of the MutL
homologues was the appreciation of sequence similarity between the
highly conserved NH2 termini of the MutLs and a new family of ATPases (11, 44). The so-called GHL ATPase family is
comprised of E. coli gyrase b subunit, the Hsp90 homologues,
and the MutL homologues (10, 20). The supercoiling activity
of E. coli DNA gyrase is dependent on the ATPase activity of
the homodimeric gyrase b subunits (65). Recently, the
homodimer Hsp90 has been demonstrated to have a weak intrinsic ATPase
activity required for Hsp90 function (47, 50). The crystal
structures of the NH2 termini of Hsp90 and gyrase b
revealed strong structural similarity within their ATPase motifs
(55, 56, 71). In addition, Hsp90 and gyrase b appear to have
similar ATPase cycles, which include functionally important
NH2-terminal conformational changes (4, 25, 26, 55,
56, 71). The NH2-terminal conformational changes for
gyrase b have been associated with dimerization of the
NH2-terminal domains in the ATP-bound form (4, 55, 56, 71). Recently, the crystal structure of an
NH2-terminal fragment of MutL was solved and demonstrated
that MutL possesses an ATP-binding pocket homologous to the gyrase b
and Hsp90 proteins. In addition, MutL appears to have the
ATPase-dependent NH2-terminal dimerization cycle found in
the other GHL family member. Interestingly, Ban et al. reported that
the NH2-terminal-dimerized, ATP-bound form of MutL could
activate the MutH endonuclease in a MutS-independent manner (9,
10).
Our previous studies have shown the importance of the NH2
terminus of yeast Mlh1p and Pms1p in MMR (51). The
abovementioned findings for the GHL family of proteins now present a
working paradigm for detailed studies of the ATPase motifs found in the eukaryotic MutL homologues. In this report, we investigate the function
of predicted ATPase motifs in S. cerevisiae MutL
(Mlh1p-Pms1p). Our results suggest that yeast MutL
has structural
and functional properties consistent with other members of the GHL
family of ATPases. Specifically, genetic results suggest that the
ATPase motifs of both Mlh1p and Pms1p are absolutely required for MMR in vivo. In addition, biochemical and in vivo findings suggest that ATP
binding induces conformational changes in MutL
that are associated
with heterodimerization between the NH2 termini of Mlh1p
and Pms1p. Surprisingly, our genetic results suggest differential
requirements for Mlh1p and Pms1p ATPase motifs during MMR.
 |
MATERIALS AND METHODS |
Strains and media.
E. coli strains DH5
and DH-10B
were used for plasmid construction and amplification. E. coli MAX Efficiency DH-10Bac [F
mcrA
D(mrr-hsdRMS-mcrBC)
80dlacZDM15
lacX74 deoR recA1 endA1 araD139
(ara,
leu)7697 galU galK 
rpsL
nupG/bMON14272/pMON7124] was used to produce recombinant baculoviruses as described below under "Expression and purification of yeast MutL
." The S. cerevisiae strains used in this
study are described in Table 1. Bacterial
and yeast strains were grown under conditions described previously
(51). Yeast transformations were performed by the
polyethylene glycol-lithium acetate method (24).
Deletions of
mlh1
and
pms1
in the GCY35
(
45) background were created as described previously
(
51,
53).
Genomic
mlh1 point mutant strains used in this study (Table
1) were created by a two-step recombination procedure. Targeting
constructs pYI-mlh1-31, and -98 were digested with
PstI and
transformed
into the appropriate strains. Purified Ura
+
transformants were replica plated onto yeast extract-peptone-dextrose
(YPD) plates and grown overnight. YPD replica plates were replica
plated to 5-fluoroorotic acid (5-FOA)-containing plates. Purified
5-FOA
R isolates were screened for retention of the
mlh1 point mutant
allele by the mutator replica patch test
for
hom3-10 reversion,
and the point mutation was confirmed
by sequencing a PCR amplicon
of the
MLH1 gene. Both alleles
were screened by using the same
PCR oligonucleotides: yMLH1.S
(5'-CGGGATCCCTCGAGACACCATGTCTCTCAGAATAAAAGC-3')
and
yMLH1-F96A anchor.R (5'-GGAGTAAACGCTGTTCAAAGCTCT-3').
Alleles
mlh1-E31A and
mlh1-G98A were
sequenced with the oligonucleotides
ymlh1-98.AS
(5'-GGCTAAAGCTTCAGCTCGGAATCCATACGTTTGAATCTG-3') and
ymlh1-31.S (5'-CCCGTAAATGCTCTCAAAGCTATGATGGAGAATTCC-3'),
respectively.
All double point mutant strains, PTY400, -500, -501, and -600,
were generated by mutation of the
MLH1 gene
last.
Genomic
pms1 point mutant strains were created similarly by
using targeting constructs pYI-pms1-61 and -128 TV II digested
with
MluI or
XbaI. PCR oligonucleotides
yPMS1-86.S (5'-GTATGTCCAGCAGTTTCCATCAG-3')
and
yPMS1-1281.AS (5'-GCAAGCTTATCGGTGTATTTCCCAAGCATTC-3')
were
used to amplify a portion of the
PMS1 gene,
and the resulting
PCR product was sequenced with oligonucleotides
ypms1-128.AS (5'-GAAGATAGGGCCTCAGCTCTAAACCCTAACGTCTGTACTTTAGC-3')
and ypms1-61.S
(5'-ACAACTGCAGTGAAAGCTCTCGTTGATAATAGTATAGATGCG-3')
for the
pms1-E61A and
pms1-G128A alleles,
respectively.
Disruptions of
mlh3
were generated by transformation with
XhoI- and
SacI-digested
p

mlh3::hisG-URA3-hisG (
1) and selection
on

Ura dropout media. Targeting of
mlh3 was confirmed by
Southern
analysis of
EcoRV-digested genomic DNA with a
PCR-generated probe
by using oligonucleotides
5'-TGGTTCGCCGATCTTATC-3' and
5'-AAATACACTCCCTCTCCATCAC-3'.
Plasmid construction.
All DNA manipulations were performed
by standard molecular biology procedures (40). Automated DNA
sequencing was done at the Vollum Institute core sequencing facilities
with an ABI automated sequencer.
(i) Targeting vectors.
pYI-mlh1-31 was created as follows.
The MLH1 open reading frame (ORF) and approximately 800 bp
of upstream sequence were cloned into pYI-lacZ. The E31A
mutation was generated in the resultant construct by using the
Quikchange Site-Directed Mutagenesis kit (Stratagene) and the following
oligonucleotides: ymlh1-31.S and ymlh1-31.AS
(5'-GGAATTCTCCATCATAGCTTTGAGAGCATTTACGGG-3'). The desired
mutations were detected by sequencing with oligonucleotide ymlh1-98.AS.
An approximately 400-bp KpnI fragment containing the E31A
mutation was cloned back into the parental construct to erase the
potential for second site mutations elsewhere in the construct.
pYI-mlh1-98 was created in a similar fashion, except the following
oligonucleotides were used instead: ymlh1-98.S
(5'-CAGATTCAAACGTATGGATTCCGAGCTGAAGCTTTAGCC-3') and
ymlh1-98.AS for mutagenesis and ymlh1-31.S for identification of the
point mutation.
pYI-pms1-61 TV II was constructed as follows. pYI-ypms1 TV II was
generated by PCR to contain 686 bp upstream of the ATG codon
to
position 2426 of the
yPMS1 ORF in pYI-
lacZ. A
PstI-
BspMI fragment
from pFB-ypms1-61 (see below)
that contained the E61A codon mutation
was used to replace the
wild-type
PstI-
BspMI fragment of pYI-ypms1
TV II
to create pYI-pms1-61 TV II. pYI-pms1-128 TV II was created
similarly
with a
PstI-
BspMI fragment from pFB-ypms1-128
(see below)
that contained the G128A codon mutation. pYI-ypms1-61 and
-128
TV II were both shown to be free of second site mutations in the
germane regions by
sequencing.
p

mlh3::hisG-URA3-hisG was a kind gift from David Jacobson
(Oregon Health Sciences University, Department of Molecular and
Medical
Genetics).
(ii) Two-hybrid vectors.
All of the following constructs
were sequenced to confirm that point mutations were present in the
desired plasmids. pNBTM116 was a generous gift of Stanley Hollenberg
(Oregon Health Sciences University, Department of Cell and
Developmental Biology) and allows construction of two-hybrid "bait"
fusions with the lexA DNA binding domain fused at the
carboxy terminus of the bait protein. pNBTM-mlh1 N-354 was engineered
with the oligonucleotides ymlh1 N-anchor.S
(5'-CGGGATCCATGTCTCTCAGAATAAAAGCAC-3') and ymlh1 N-354.AS (5'-AGCCTCGAGCTCTGGCTTGTTTGTTGAAATTG-3') to generate a PCR
amplicon that was cloned into pNBTM116 at the BamHI and
XhoI sites. Plasmid pNBTM-mlh1-31 N-354 was generated in an
identical fashion, but the PCR was performed on template DNA that
contained the E31A codon mutation.
pNBTM-pms1 N-401 and pNBTM-pms1-61 N-401 were generated by using a
similar procedure to pNBTM-mlh1 N-354, but with oligonucleotides
ypms1
N-anchor.S (5'-CGGGATCCAAAATGTTTCACCACATCGAAAAC-3')
and
ypms1 N-401.AS
(5'-AGCCTCGAGTTGTGAGCACATTCTTTTGGG-3').
The pNBTM-pms1-61,
-128 N-401 double point mutant was
made by using the Quikchange
Site-Directed Mutagenesis kit (Stratagene)
with plasmid pNBTM-pms1-61
N-401 and the ypms1-128.S and -.AS
oligonucleotides.
pCAD3 analogous to pNBTM116 allows fusion of the GAL4 activation domain
to the carboxy terminus of the "prey" protein (
54).
pCAD-mlh1 N-354 and alanine point mutant version E31A were constructed
by cloning a PCR product generated from oligonucleotides ymlh1
N-anchor.S and ymlh1 N-354(
BamHI).AS
(5'-AGCGGATCCCTCTGGCTTGTTTGTTGAAATTG-3')
into pCAD3 at
a
BamHI site. Plasmids with the correct insert orientation
were isolated for further study. The pCAD-mlh1-31, -98 N-354 double
point mutant was made by using the Quikchange Site-Directed Mutagenesis
kit (Stratagene) with construct pCAD-mlh1-31 N-354 and the ymlh1-98.S
and -.AS
oligonucleotides.
pCAD-pms1-61 N-401 was created in a likewise fashion, except that
oligonucleotides ypms1 N-anchor.S and ypms1 N-401 (BamHI).AS
(5'-AGCGGATCCTTGTGAGCACATTCTTTTGGG-3') were
used.
(iii) Baculovirus plasmids.
The 6×His-MLH1 recombinant
baculovirus was constructed as follows. A PCR product was generated
that engineered a 6×His affinity tag in frame with the MLH1
ORF after the initiator methionine. This 6×His-encoding PCR product
was cloned into the BamHI and NdeI restriction
sites of pBTM-MLH1, replacing approximately 360 bp of the native gene.
Automated sequencing of the construct confirmed that the 6×His tag was
in frame with the MLH1 ORF and that no PCR-generated
mutations arose. The 6×His-MLH1 ORF was then cloned into
pFastBac DUAL (pFBD) (Life Technologies) by using polylinker sites
BamHI and SalI. Based upon mutator assays, the
6×His epitope-tagged Mlh1p functionally complemented an
mlh1
strain (data not shown).
The PMS1 recombinant baculovirus was produced as follows. The
PMS1 ORF was removed from genomic clone pJH480-PMS1 by using
AseI and
SalI restriction enzymes and ligated to
a synthetic linker
containing
AseI- and
NcoI-compatible overhangs. This
PMS1 ORF
ligation
product was then cloned into pEAE51 at sites
NcoI and
SalI, replacing the
MSH6 ORF (
3). The
PMS1 ORF was then excised
with
XhoI and
SalI restriction enzymes and ligated into the pFastBac1
(pFB) (Life Technologies) polylinker at an
XhoI site. A
pFB-PMS1
construct in the desired orientation was identified and
sequenced
to examine the site of the synthetic
linker.
Two-hybrid analysis and
-galactosidase assays.
Protein-protein interactions were assessed by the two-hybrid technique.
Bait and prey plasmids were transformed into L40 and AMR70 yeast,
respectively (69). L40 bait strains were mated with AMR70
prey strains as described previously (67). Growth on
Ura
Trp
Leu (
UTL) plates indicated efficiency of mating, while growth
on
Trp
His
Ura
Leu
Lys (
THULL) plates indicated bait-prey
interaction. Expression of a subset of constructs was confirmed by
Western blotting of L40 strains with the indicated bait or prey.
Extracts were made from 10-ml saturated cultures by glass bead lysis
for 30 min at 4°C in a mixture of 25 mM Tris (pH 7.5), 1 mM EDTA, 10 mM
-mercaptoethanol (
-ME), 1 mM phenylmethylsulfonyl fluoride
(PMSF), and Complete Proteolysis Inhibitor (Roche Molecular Biochemicals) and centrifuged at 14,000 × g for 5 min;
concentrations of soluble protein fractions were determined by Bradford
(Bio-Rad). Ten to 15 µg of each extract was separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10%
polyacrylamide gels, transferred to nylon membranes (Ambion), probed
with the either anti-GAL4-TA (1:200 dilution) or anti-lexA-DB (1:200
dilution) (Santa Cruz Bio. Inc.) followed by the appropriate secondary
antibody, and detected by chemiluminescence.
Diploid L40/AMR70 is homozygous for a second chromosomal lexA-GAL4A
reporter system,
URA3::(
lexAop)
8-
lacZ.

-Galactosidase
assays were performed on

THULL plates as described
previously
(
67). Reaction mixtures were placed at 30°C
until the desired
blue color development was
achieved.
Measurement of mutation rates and CAN1 mutational
spectrum analysis.
Briefly, strains were streak purified before
the mutation rate assay, individual colonies were grown to saturation
in YPD, and then various dilutions were plated onto complete synthetic medium (CSM),
Thr and +canavanine (+CAN [60 µg/ml]) plates and colonies were counted after 2 to 3 days of growth at 30°C. Rates were
determined as previously described (51). Statistical
analyses were performed by using a two-tailed Mann-Whitney test with
Prism 2.0a software (GraphPad Software, Inc.); P values of
<0.05 were considered statistically significant.
Canavanine resistance (Can
R) mutations were determined from
genomic preparations by using the glass bead lysis method, followed
by
PCR of the
CAN1 gene, as described previously
(
66), and direct
sequencing of the QIAquick
(Qiagen)-purified PCR amplicon with
an ABI automated
sequencer.
Expression and purification of yeast MutL
.
The Bac-to-Bac
Baculovirus (Life Technologies) expression system was used to express
MutL
in Spodoptera frugiperda (Sf9) cells infected with
recombinant baculovirus. Recombinant baculoviruses that express
6×His-Mlh1p and Pms1p were created as described in the manufacturer's
instructions (Bac-to-Bac Baculovirus expression system; Life
Technologies). A 200-ml culture of Sf9 cells (typically 1 × 106 to 2 × 106 cells/ml) was coinfected
with recombinant baculoviruses at multiplicities of infection of 2 to
2.5 and 11 to 15 for 6×His-Mlh1p- and Pms1p-expressing baculoviruses,
respectively. Cells were harvested at 44 to 48 h of coinfection,
frozen as cell pellets with liquid nitrogen, and stored at
80°C.
All subsequent steps were performed at 0 to 4°C, and purification was
monitored by SDS-PAGE and Western blot analysis. Western
blots were
probed with a 1:1,000 dilution of anti-4×His monoclonal
antibody
(Qiagen) or a cross-reacting 1:100 dilution of anti-hPms2p
polyclonal
antibody and then visualized by using a 1:2,000 dilution
of anti-mouse
immunoglobulin G (mIgG)-horseradish peroxidase mIgG-(HRP)
(Pierce) or a
1:1,250 dilution of anti-rat IgG (rIgG) rIgG-HRP
(Bio-Rad),
respectively, and Enhanced Luminol reagent (NEN). All
buffers included
0.5 to 1 mM PMSF (Sigma Chemicals), 4 to 10 µg
of leupeptin per ml
(Sigma Chemicals), and 4 to 10 µg of aprotinin
per ml (Sigma
Chemicals). Cell pellets were resuspended in 5 ml
of Sf9 lysis buffer
per gram of wet cell pellet (Sf9 lysis buffer:
50 mM Tris-HCl [pH
7.6], 5 mM

-ME, 100 mM KCl, Complete-Mini
EDTA Free pills [1
pill/5 or 10 ml] [Roche Molecular Biochemicals],
1% Nonidet P-40
[NP-40] [Sigma Chemicals]). The cell lysate was
then spun at
10,000 ×
g for 10 min. The cleared lysate was
incubated
in a batch with 1.0 ml of a 50% slurry of
Ni-nitrilotriacetic
acid agarose resin (Qiagen) in buffer H (400 mM
NaCl, 25 mM Tris-HCl
[pH 7.8], 20% glycerol, 5 mM

-ME) plus 0.6 M
(NH
4)
2SO
4 and 10
to 15 mM imidazole
(pH 8) for 1 h. The resin was washed in a batch
three times: once
with 40 ml of buffer H plus 0.6 M
(NH
4)
2SO
4 and 25 mM imidazole and
twice with 40 ml of buffer H plus 0.6
M
(NH
4)
2SO
4 and 50 mM imidazole. The
resin was loaded onto an
Econo-column (Bio-Rad) and eluted with buffer
H plus 0.5 M imidazole.
Peak fractions were pooled, desalted into
buffer T (50 mM Tris-HCl
[pH 7.8], 10% glyercol, 1 mM
dithiothreitol) plus 100 mM NaCl
and 0.01% NP-40 by using PD-10
desalting columns (Amersham Pharmacia
Biotechnologies), and further
purified on a 1-ml HiTrap heparin
column by using a 20-ml gradient from
100 mM to 1 M NaCl. Peak
fractions were concentrated with Vivaspin 500 (50,000 molecular
weight cutoff) (Vivascience, Ltd., Brinbrook Hill,
United Kingdom)
as described by the manufacturers. Concentrated
fractions were
frozen in liquid nitrogen and stored at

80°C.
MutL

protein concentration
was determined by scanning densitometry
of a Coomassie blue-stained
gel by using bovine serum albumin standards
(Pierce) and analyzed
with NIH image 1.61
software.
Limited proteolysis assays.
Limited proteolysis reaction
mixtures (20 µl) consisted of 150 ng of MutL
, 30 mM Tris (pH 7.6),
150 mM NaCl, 5 mM MgCl2, and 0.5 mM dithioerythritol with
or without 5 mM ATP, adenosine 5'-(
,
-imino)triphosphate
(AMP-PNP), ATP
S, or ADP. Reaction mixtures were incubated for 15 min
at 30°C, followed by the addition of 50 ng of modified trypsin
(Promega Corp.), incubation at 30°C for a specified interval,
addition of SDS-sample buffer, and boiling for 7 min. Processed
reactions were separated on an SDS-PAGE (10% polyacrylamide) gel and
transferred onto polyvinylidene difluoride membranes (Ambion), and
Western blotting was performed with specified antibodies. Anti-4×His
Western blots were performed as described above. The anti-Mlh1p
polyclonal antibody was a kind gift of T. Kunkel (National Institute of
Environmental Health Sciences) and was generated against a
COOH-terminal peptide of yeast Mlh1p. The anti-Mlh1p polyclonal
antibody was used to probe limited proteolysis blots at a 1:10,000
dilution and detected as described above.
 |
RESULTS |
Predicted ATPase residues of MutL
are necessary for MMR in
vivo.
To examine the importance of putative ATPase domains of
S. cerevisiae Mlh1p and Pms1p, we examined the effects of
mutations introduced at two of the ATPase motifs, I and III, conserved
in the GHL family (Fig. 1). We chose to
examine residues E31 and E61 of Mlh1p and Pms1p, respectively, because
mutations at the homologous glutamate of MutL, gyrase B, and Hsp90 have
been shown to eliminate ATP hydrolysis with little or no effect on ATP
binding (9, 10, 34, 47, 50). In motif III, we focused on
residues G98 and G128 of Mlh1p and Pms1p, respectively, which are
modeled to affect ATP binding and/or an associated conformational
change induced upon ATP binding (9, 10, 26, 47, 50). For
brevity, we will refer to alanine substitution mutations at E31 and E61 of Mlh1p and Pms1p, respectively, as hydrolysis mutations and the
mutations G98A and G128A in Mlh1p and Pms1p, respectively, as
ATP-binding mutations.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
NH2-terminal ATPase domains of GHL ATPases.
ATPase motifs I to IV are designated by black boxes, and sequences are
shown above motif boxes. Numbers correspond to the number of amino
acids preceding or following sequence alignments. Boldface letters are
the absolutely conserved residues that were substituted for with
alanine in Mlh1p and Pms1p.
|
|
To address whether the ATP hydrolysis and ATP-binding motifs of MutL

are necessary for mutation avoidance by MMR, double
point mutants
(e.g.,
mlh1-E31A pms1-E61A) were generated and examined
for
their spontaneous mutation rate (see Materials and Methods).
We
analyzed the effects of double hydrolysis and double binding
mutants by
using two mutator rate assays: reversion of
hom3-10 and
forward mutation at
CAN1. Relative to the wild-type strain,
both the double ATP hydrolysis mutant (strain PTY400) and the
double
ATP-binding mutant (strain PTY600) exhibited spontaneous
mutation rates
similar to those observed in
mlh1
and
pms1
strains
(Table
2, compare strains PTY400
and PTY600 with PTY100 and PTY101).
The mutator phenotype of a complex
double mutant,
mlh1 hydrolysis
mutant plus
pms1
binding mutant, or vice versa, was also similar
to that of an
MMR-deficient (e.g.,
mlh1
) strain (Table
2, compare
strains PTY500 and PTY501 with PTY100 and PTY101). These data
indicate
that any combinations of double ATP hydrolysis and/or
binding mutations
affecting MutL

result in defects in the mutation
avoidance functions
of MMR comparable to the defects seen in
mlh1
and
pms1
strains.
Mutator effects of single alterations in the putative ATPase
domains of S. cerevisiae MutL
.
To examine the
individual contributions of Mlh1p and Pms1p ATPase motifs to MutL
function, we examined the effect of single mutations on mutation
avoidance. As shown in Table 2, the single mutations affecting the
ATPase motifs had effects on mutation avoidance that were significantly
less than the corresponding mlh1
and pms1
strains, with the exception of the mlh1 binding mutant
(PTY300), the effect of which was only slightly less than the
mlh1
strain (PTY100). Interestingly, the homologous
ATPase mutations made in MLH1 and PMS1 had
different effects on mutation avoidance. The mlh1 hydrolysis
mutant (PTY200) displayed 16-fold and 7-fold higher rates of mutation
at hom3-10 and CAN1, respectively, than the
corresponding pms1 hydrolysis mutant strain PTY201
(P < 0.0286 for both loci). Likewise, the
mlh1 binding mutant (PTY300) showed 9- and 5.5-fold higher
rates of mutation at hom3-10 and CAN1,
respectively, than the corresponding pms1 binding mutant strain PTY301 (P < 0.0286 for both loci). One trivial
explanation for the differential effects of homologous mlh1
and pms1 mutations on mutation avoidance was that
MLH3, which is involved in a minor mutation avoidance
pathway (22), compensates for the pms1 mutations. However, as shown in Table 2, pms1 point mutant strains
deleted for MLH3, PTY202 (pms1-E61A mlh3
), and
PTY302 (pms1-G128A mlh3
) still demonstrated mutation
rates significantly smaller than that observed for the respective
homologous mlh1 ATPase point mutant strains PTY200
(mlh1-E31A) and PTY300 (mlh1-G98A) (P < 0.0159 for PTY200 versus PTY202 and P < 0.0286
for PTY300 versus PTY302). These results suggest that the differences
seen between homologous mlh1 and pms1 ATPase
point mutations with respect to mutation rate are not due to the
redundant functions of MLH3, but rather infer an intrinsic
asymmetry within the MutL
complex.
In addition to the differential effects of
mlh1 versus
pms1 mutants noted above, we also observed that ATP-binding
mutations
produced more severe effects on mutation avoidance than did
ATP
hydrolysis mutations. Both ATP-binding mutant strains PTY300
(
mlh1-G98A)
and PTY301 (
pms1-G128A) exhibited a
two- to fourfold higher rate
of spontaneous mutation at
hom3-10 and
CAN1 relative to the hydrolysis
mutants PTY200 (
mlh1-E31A) and PTY201
(
pms1-E61A), respectively
(all comparisons had a
P value of <0.0286). These results suggest
that individual
ATP binding mutations of Mlh1p and Pms1p produce
greater effects on the
mutation avoidance functions of MMR than
the individual hydrolysis
mutations.
To better define the effects of individual Mlh1p and Pms1p ATPase
mutations on MMR, we examined the mutational spectra at
the
CAN1 reporter.
CAN1 reports base substitutions,
frameshifts,
deletions, insertions, and large chromosomal
rearrangements (
15).
As seen in Table
3, the spectra of deletion strains
PTY100 (
mlh1
),
PTY101 (
pms1
), and PTY104
(
pms1
mlh3
) and point mutant strains
PTY200
(
mlh1-E31A) and PTY300 (
mlh1-G98A) showed a
preponderance
of frameshift mutations (FS) relative to base
substitutions (BS),
similar to previously published reports for an
msh2
strain (
66).
In contrast, strain PTY301
(
pms1-G128A) showed a different spectrum,
namely, a majority
of BS, represented in Table
3 by an FS/BS
ratio of 0.8. Because the
mutation rate of PTY301 (
pms1-G128A)
for
CANR is only fourfold greater than the wild-type
rate (Table
2),
one-quarter of the mutations seen with PTY301 represent
the wild-type
spectrum. Correcting for the wild-type contribution, we
still
observed a majority of base substitutions (10 of 18 [56%]
versus
7.5 of 13.5 [56%]). Next, because
MLH3 is
partially redundant
with
PMS1 in correcting frameshift
mutations, we examined the
CAN1 spectrum in a
pms1-G128A mlh3
strain (PTY302). As shown
in Table
3, the
pms1-G128A mlh3
strain (PTY302) showed a spectrum
at
CAN1 that was indistinguishable from that of an MMR-null
strain
(FS/BS ratio of 3.3). In contrast to the asymmetry observed with
the mutation rates, the spectrum results indicate that the
mlh1 and
pms1 ATPase mutations result in the same
mutational spectra.
MutL
undergoes an ATP-dependent conformational
change.
To investigate further the role of candidate
ATP-binding or hydrolysis motifs in MutL
function, we used limited
proteolysis to examine the effects of adenine nucleotides on the
conformation of recombinant MutL
purified from insect cells (data
not shown). We used an antibody directed against the 6×His tag at the
NH2 terminus of Mlh1p to detect NH2-terminal
fragments following limited proteolysis. As depicted in Fig.
2a, the presence of ATP led to the
protection of distinct NH2-terminal fragments of Mlh1p from trypsin proteolysis. The protected NH2-terminal fragments
of approximately 42 and 38 kDa coincide with the E. coli
MutL LN40 thrombin proteolytic fragment that possessed the core ATPase
domain (9, 10). We did not observe any differences between
MutL
in the presence or absence of ATP when using a polyclonal
antibody directed against the COOH terminus of Mlh1p (data not shown),
suggesting that the COOH terminus of Mlh1p does not undergo an
ATP-dependent conformational change. However, we did detect an
approximately 30-kDa band that was resistant to proteolysis in the
presence or absence of ATP even after a 30-min incubation with 750 ng
of trypsin (data not shown). This highly trypsin-resistant Mlh1p
COOH-terminal fragment may represent the COOH-terminal
heterodimerization domain of Mlh1p. As shown in Fig. 2b, lanes 3 to 5 demonstrate that nonhydrolyzable ATP analogs AMP-PNP and ATP
S, as
well as ADP, also protect the NH2 terminus of Mlh1p from
trypsin proteolysis. Qualitatively, the relative levels of protection
from proteolysis in the presence of nucleotide are as follows: ATP
AMP-PNP > ATP
S > ADP. As demonstrated for ATP, we
saw no differential protection of the COOH terminus of Mlh1p in
the presence of ADP, AMP-PNP, or ATP
S by reprobing with the antibody
directed against the COOH terminus of Mlh1p (data not shown). The
limited proteolysis results indicate that at least the Mlh1p
NH2 terminus of MutL
undergoes an ATP-binding-dependent conformational change. We were unable to address whether the
NH2 terminus of Pms1p undergoes a similar ATP-dependent
conformational change, because an antibody specific for the
NH2 terminus of Pms1p antibody was not available. However,
as described below, yeast two-hybrid results suggest that Pms1p also
undergoes an ATP-dependent conformational change.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Adenine nucleotides alter trypsin sensitivity of
MutL . (a) One hundred fifty nanograms of MutL was subjected to
proteolysis with modified trypsin as described in Materials and Methods
in the presence or absence of 5 mM ATP for the indicated time at
30°C. Products were treated with SDS-sample buffer, boiled, separated
on an SDS-PAGE (10% polyacrylamide) gel, and detected by
immunoblotting with anti-4×His antibody. Arrows denote full-length
6×His-Mlh1p, and asterisks designate NH2-terminal (term.)
fragments of 6×His-Mlh1p that are protected from proteolysis in the
presence of ATP. Equal loading of samples and even transfer of the blot
were demonstrated by using a polyclonal antibody raised against the
COOH terminus of Mlh1p (data not shown). (b) The same analysis was
performed as described for panel a, but the effects of 5 mM adenine
nucleotides ADP, AMP-PNP, and ATP S were examined.
|
|
ATP binding promotes heterodimerization of the NH2
termini of MutL
in vivo.
ATP-binding-dependent conformational
changes in other GHL family members are associated with dimerization of
their NH2-terminal ATP binding domains (9, 71).
To inquire into the functional significance of the ATP-dependent
conformational change data described above, we used the yeast
two-hybrid system to assay interactions between wild-type and mutant
NH2-terminal fragments of Mlh1p and Pms1p. Based upon
sequence alignments with GHL family members, the fragments 1 to 354 and
1 to 401 of Mlh1p and Pms1p, respectively, should each contain the
structural elements necessary for ATP binding and hydrolysis
(9). These NH2-terminal fragments of Mlh1p and
Pms1p were fused at their COOH termini to either the lexA DNA binding
domain or the GAL4 activation domain (Fig.
3a). Consistent with our previous studies
(51), no interaction was seen between wild-type Mlh1p and
Pms1p NH2-terminal fragments (Fig. 3a, group I). As stated
before, homologous ATP hydrolysis mutations in other GHL ATPases have
been shown to abolish ATP hydrolysis activity with little or no effect
on ATP binding (9, 10, 34, 47, 50). Interestingly, for an
NH2-terminal fragment of gyrase b, ATP binding was only
observed in vitro for a hydrolysis-deficient form (34).
Therefore, we reasoned that ATP hydrolysis mutations in the
NH2 termini of both Mlh1p and Pms1p might prolong a double ATP-bound state in vivo and allow interaction to be detected by the
yeast two hybrid assay. Indeed, as shown in Fig. 3a (group III), a
robust interaction was seen when both Mlh1p and Pms1p NH2-terminal fragments possessed ATP hydrolysis mutations.
However, the interaction was not observed when only the Mlh1p or Pms1p fragment possessed the ATP hydrolysis mutation E31A or E61A,
respectively (Fig. 3a, group II). To demonstrate that this novel
interaction was dependent on the putative ATP-binding activities of
Mlh1p and Pms1p, we superimposed either the mlh1-G98A or
pms1-G128A ATP-binding mutation onto the
hydrolysis-defective NH2-terminal fragments of mlh1p-E31A
or pms1p-E61A, respectively. Supporting our hypothesis, we observed
that superimposing a mutation designed to prevent the putative
ATP-binding or conformational change in one fragment ablated the
two-hybrid interaction (Fig. 3a, compare groups III and IV).
Interestingly, the two-hybrid interaction seen in Fig. 3a, group III,
was specific only for the mlh1p-E31A and pms1p-E61A
NH2-terminal fusion pairs, because the NH2
terminus of mlh1p-E31A did not interact with itself (data not shown).
The same observation was seen with the NH2 terminus of
pms1p-E61A (data not shown), suggesting that, similar to their
respective COOH-terminal domains (51), the NH2
termini of Mlh1p and Pms1p do not homodimerize. The two-hybrid results
of Fig. 3a are not due to ATP hydrolysis or ATP-binding mutations
grossly affecting expression or stability of the fusion proteins,
because Western analysis demonstrates that all fusion proteins are
expressed at similar levels (Fig. 3b). Taken together, the two-hybrid
results suggest that ATP binding, but not hydrolysis, by both Mlh1p and Pms1p is necessary for MutL
NH2-terminal
heterodimerization.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 3.
Two-hybrid analysis detects NH2-terminal
Mlh1p and Pms1p interaction. (a) Boxes correspond to bait and prey
constructs tested for interaction. The residues included in the fusions
are indicated below the group I and V constructs, respectively. Amino
acid substitutions designated above each construct are indicated by
black bars within the construct boxes. Interaction is scored as growth
on HIS media and blue color development with the substrate X-Gal
(5-bromo-4-chloro-3-indolyl- -D-galactopyranoside) as
described in Materials and Methods. Group I, wild-type
NH2-terminal fusion fragments; group II, one
NH2-terminal fusion fragment contains a hydrolysis point
mutation; group III, both NH2-terminal fusion fragments
contain hydrolysis point mutations; group IV, one
NH2-terminal fusion fragment has the indicated compound
mutations; and group V, positive control reaction with full-length
Pms1p and Mlh1p. (b) Western analysis of L40 strains with two-hybrid
constructs from panel a using anti-GAL4-TA or anti-lexA-DB monoclonal
antibody as described in Materials and Methods. Lanes: 1, pCAD3 (empty
vector); 2, pCAD-mlh1 N-354; 3, pCAD-mlh1-E31A N-354; 4, pCAD-mlh1-E31A, -G98A N-354; 5, pNBTM (lexA); 6, pNBTM-pms1 N-401; 7, pNBTM-pms1-E61A N-401; 8, pNBTM-pms1-E61A, -G128A N-401. Fusion
products and lexAp are indicated by arrowheads. The approximately
90-kDa band in lanes 1 to 4 may be endogenous Gal4p. The other bands
present in control lanes 1 and 5 and in lanes 2 to 4 and 6 to 8, respectively, represent nonspecificity by the primary and secondary
antibodies. In lanes 6 to 8, the faster-migrating specific anti-lexA-DB
reacting species is unknown, but may be a pms1p(1-401)-lexAp
degradation product.
|
|
 |
DISCUSSION |
Although clearly crucial for MMR, little information exists on the
function of the major MutL activity in yeast, MutL
, composed of
Mlh1p and Pms1p. Previous studies with yeast have defined COOH-terminal domains as important for Mlh1p and Pms1p interaction (51)
and conserved NH2-terminal residues as necessary for MMR
activity (51, 63). Recent investigations of MutL and other
members of the GHL family of ATPases have suggested guidelines for more detailed studies of MutL
function. Here, we present evidence defining yeast MutL
as a functional member of the GHL ATPase superfamily. First, residues critical for the ATPase function of GHL
family members, when substituted for alanine in both Mlh1p and Pms1p,
disrupt MMR. Second, adenine nucleotide binding protects the
NH2 terminus of Mlh1p from trypsin proteolysis, suggesting that MutL
undergoes ATP-dependent conformational changes. Third, results from the two-hybrid system suggest that one consequence of the
ATP-induced conformational changes is an interaction between the
NH2 termini of Mlh1p and Pms1p. Finally, analysis of single mlh1 and pms1 ATPase motif mutants indicates a
functional asymmetry within yeast MutL
.
GHL family members appear to share an ATPase cycle that is highlighted
by an NH2-terminal dimerized intermediate in the ATP-bound form (4, 9, 10, 55-57, 71). In the case of MutL, this ATP-binding-induced NH2-terminal dimerization activated
MutH endonuclease in vitro (10). The limited proteolysis and
two-hybrid analyses presented here support an ATPase cycle for MutL
,
composed of at least four intermediates, that is similar to those of
other GHL family members (Fig. 4).
Limited proteolysis suggests that MutL
undergoes a conformational
change in vitro that is dependent on ATP binding, as AMP-PNP (and to a
lesser extent ATP
S) produced the same effect as ATP (Fig. 4,
intermediate 2). Furthermore, we observed a specific two-hybrid
interaction between Mlh1p and Pms1p NH2-terminal fragments,
each containing ATP hydrolysis mutations (Fig. 4, intermediate 3).
Interaction was not detected by a yeast two-hybrid assay with wild-type
NH2-terminal fragments of Mlh1p and Pms1p, presumably
because ATP hydrolysis renders the interaction transient. In further
support of the existence of intermediate 3, our recent observations
suggest that the double hydrolysis mutant form of MutL
is highly
resistant to trypsin-limited proteolysis even without added ATP
(unpublished observations). Also, that ADP provided some protection
from limited proteolysis suggests the existence of an ADP-bound
intermediate (Fig. 4, intermediate 4). Double mutant mlh1
pms1 strains with alanine substitutions at ATP hydrolysis or
ATP-binding residues showed increased spontaneous mutation rates
indistinguishable from those of completely MMR-defective cells. This
double mutant analysis suggests that the candidate ATPase domains of
both Mlh1p and Pm1p and the ATPase cycle described above are required
for MutL
function in yeast MMR for mutation avoidance. It is
intriguing to speculate on the function of the NH2-terminal
ATP-bound MutL
intermediate, because similar findings from other GHL
ATPases (25, 55-57), namely MutL (10), suggest that this MutL
intermediate may play a significant role in
coordinating downstream steps with known and perhaps unidentified MMR
proteins. Although our data are consistent with the ATPase cycle
represented in Fig. 4, further biochemical work with MutL
is
required to confirm and characterize the contribution of Mlh1p and
Pms1p ATP binding and hydrolysis activities to MutL
function.
Similar to earlier work from the Hsp90 field (35, 61), we
have not been able to specifically assign an intrinsic ATPase activity
to MutL
with our current protein preparations (unpublished
observations). However, similar to what is currently known for GHL
ATPases (9, 10, 34, 47, 50), our double mlh1 pms1
hydrolysis mutant phenotype and our two-hybrid results suggest a
crucial role for ATP hydrolysis during mutation avoidance in yeast MMR
(Table 2).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
A model for the yeast MutL ATPase cycle. Briefly,
intermediate 1 is the nucleotide-free state. ATP binding induces
conformational changes in the NH2 termini of Mlh1p and
Pms1p, represented by a change in shape from rectangular to oval that
occurs in the step(s) between intermediates 2 and 3. Intermediate 3 is
heterodimerization of the NH2 termini of Mlh1p and Pms1p in
the ATP-bound state. Intermediate 4 is the ADP-bound form following ATP
hydrolysis. The mlh1-G98A and pms1-G128A
ATP-binding mutants were constructed to affect the transition(s) from
intermediate 1 to intermediate 2 and/or intermediate 2 to intermediate
3. In contrast, the ATP hydrolysis mutations, mlh1-E31A and
pms1-E61A, were modeled to prevent the transition from
intermediate 3 to intermediate 4. M, the NH2 terminus of
Mlh1p; P, the NH2 terminus of Pms1p; C, COOH termini of
Mlh1p and Pms1p. Each arrow may represent multiple distinct steps. This
model, which is consistent with the studies reported here, was adapted
from a model for MutL proposed by Ban and Yang (9).
|
|
Interestingly, genetic analysis revealed a functional asymmetry with
respect to the two ATPase domains of the MutL
heterodimer. Specifically, alanine substitution mutations affecting the predicted ATPase motifs of Mlh1p had a greater impact on mutation avoidance than
the corresponding mutations in Pms1p. Formally, our genetic results
argue that Mlh1p can compensate better for ATPase mutations in Pms1p
for mutation avoidance than can Pms1p for the corresponding ATPase
mutations in Mlh1p. The apparent genetic asymmetry detected for MutL
may reflect at the mechanistic level a kinetic asymmetry similar to
that observed in the homodimeric ATPases, topoisomerase II from
S. cerevisiae, and the
complex from E. coli
(6, 28, 29). Biologically, the genetic asymmetry observed
with MutL
may represent distinct but overlapping roles of Mlh1p and
Pms1p during mutation avoidance, e.g., excision tracts originating 5' versus 3' from the mismatch or IDL (18, 46) or differential roles during strand discrimination.
MutL has been referred to as a "molecular matchmaker," coupling the
mismatch binding activity of MutS to the latent endonuclease MutH
(60). One criterion of a molecular matchmaker that MutL has
always appeared to lack was an intrinsic ATPase activity. Recent work
has now identified this "missing" activity, and as suggested
previously, it appears to be critical for MutL activity in MMR (5,
9, 10). Moreover, the MutL ATPase activity was responsible for
coordinated interaction and activation of MutH in vitro
(10). In this report, we have shown that the conserved ATPase motifs of MutL
are necessary for mutation avoidance by MMR in
yeast. The role of the ATPase motifs of Mlh1p and Pms1p in other
MMR-related functions, such as meiotic (7, 8, 30, 70) and
homeologous recombination (16, 17, 31, 62), remains to be
determined. Finally, as for MutL (9, 10), the ATP-dependent
conformational changes in yeast MutL
are likely to facilitate
interaction with downstream proteins in MMR. Our ability to produce a
stable Mlh1p-Pms1p NH2-terminal interaction via the yeast
two-hybrid system may provide a means to identify these proteins.
 |
ACKNOWLEDGMENTS |
This work was supported by NSF grant MCB9631061 to R.M.L. and
OHSU Molecular Hematology Training grant 5-T32-HL07781 to P.T.T.
We thank Andrew Buermeyer, Suzanne Deschênes, Guy Tomer, and
Betsy Ferguson for helpful comments on the manuscript and Sandra Dudley
for expert technical assistance with the mutational spectra. Special
thanks go to Eric Alani and Jayson Bowers for their superb technical
advice on the MutL
purification.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular and Medical Genetics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd., L103, Portland, OR 97201-3098. Phone: (503)
494-3475. Fax: (503) 494-6886. E-mail: liskaym{at}ohsu.edu.
 |
REFERENCES |
| 1.
|
Alani, E.,
L. Cao, and N. Kleckner.
1987.
A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains.
Genetics
116:541-545[Abstract/Free Full Text].
|
| 2.
|
Alani, E.,
N.-W. Chi, and R. Kolodner.
1995.
The Saccharomyces cerevisiae Msh2 protein specifically binds to duplex oligonucleotides containing mismatched DNA base pairs and insertions.
Genes Dev.
9:234-247[Abstract/Free Full Text].
|
| 3.
|
Alani, E.,
T. Sokolsky,
B. Studamire,
J. J. Miret, and R. S. Lahue.
1997.
Genetic and biochemical analysis of Msh2p-Msh6p: role of ATP hydrolysis and Msh2p-Msh6p subunit interactions in mismatch base pair recognition.
Mol. Cell. Biol.
17:2436-2447[Abstract].
|
| 4.
|
Ali, J. A.,
A. P. Jackson,
A. J. Howells, and A. Maxwell.
1993.
The 43-kilodalton N-terminal fragment of the DNA gyrase b protein hydrolyzes ATP and binds coumarin drugs.
Biochemistry
32:2717-2724[CrossRef][Medline].
|
| 5.
|
Aronshtam, A., and M. G. Marinus.
1996.
Dominant negative mutator mutations in the mutL gene of Escherichia coli.
Nucleic Acids Res.
24:2498-2504[Abstract/Free Full Text].
|
| 6.
|
Baird, C. L.,
T. T. Harkins,
S. K. Morris, and J. E. Lindsley.
1999.
Topoisomerase II drives DNA transport by hydrolyzing one ATP.
Proc. Natl. Acad. Sci. USA
96:13685-13690[Abstract/Free Full Text].
|
| 7.
|
Baker, S.,
A. Plug,
T. Prolla,
C. Bronner,
A. Harris,
X. Yao,
D.-M. Christie,
C. Monell,
N. Arnheim,
A. Bradley,
T. Ashley, and R. Liskay.
1996.
Involvement of Mlh1 in DNA mismatch repair and meiotic crossing over.
Nat. Genet.
13:336-342[CrossRef][Medline].
|
| 8.
|
Baker, S. M.,
C. E. Bronner,
L. Zhang,
A. W. Plug,
M. Robatzek,
G. Warren,
E. A. Elliott,
J. Yu,
A. T. N. Arnheim,
R. A. Flavell, and R. M. Liskay.
1995.
Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis.
Cell
82:309-319[CrossRef][Medline].
|
| 9.
|
Ban, C.,
M. Junop, and W. Yang.
1999.
Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair.
Cell
97:85-97[CrossRef][Medline].
|
| 10.
|
Ban, C., and W. Yang.
1998.
Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis.
Cell
95:541-552[CrossRef][Medline].
|
| 11.
|
Bergerat, A.,
B. de Massy,
D. Gadelle,
P. C. Varoutas,
A. Nicolas, and P. Forterre.
1997.
An atypical topoisomerase II from Archaea with implications for meiotic recombination.
Nature
386:414-417[CrossRef][Medline].
|
| 12.
|
Bowers, J.,
T. Sokolsky,
T. Quach, and E. Alani.
1999.
A mutation in the MSH6 subunit of the Saccharomyces cerevisiae MSH2-MSH6 complex disrupts mismatch recognition.
J. Biol. Chem.
274:16115-16125[Abstract/Free Full Text].
|
| 13.
|
Bronner, C. E.,
S. M. Baker,
P. T. Morrison,
G. Warren,
L. G. Smith,
M. K. Lescoe,
M. Kane,
C. Earabino,
J. Lipford,
A. Lindblom,
P. Tannergard,
R. J. Bollag,
A. R. Godwin,
D. C. Ward,
M. Nordenskjold,
R. Fishel,
R. Kolodner, and R. M. Liskay.
1994.
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer.
Nature
368:258-261[CrossRef][Medline].
|
| 14.
|
Buermeyer, A. B.,
S. M. Deschenes,
S. M. Baker, and R. M. Liskay.
1999.
Mammalian DNA mismatch repair.
Annu. Rev. Genet.
33:533-564[CrossRef][Medline].
|
| 15.
|
Chen, C.,
B. J. Merrill,
P. J. Lau,
C. Holm, and R. D. Kolodner.
1999.
Saccharomyces cerevisiae pol30 (proliferating cell nuclear antigen) mutations impair replication fidelity and mismatch repair.
Mol. Cell. Biol.
19:7801-7815[Abstract/Free Full Text].
|
| 16.
|
Chen, W., and S. Jinks-Robertson.
1999.
The role of the mismatch repair machinery in regulating mitotic and meiotic recombination between diverged sequences in yeast.
Genetics
151:1299-1313[Abstract/Free Full Text].
|
| 17.
|
Datta, A.,
M. Hendrix,
M. Lipsitch, and S. Jinks-Robertson.
1997.
Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast.
Proc. Natl. Acad. Sci. USA
94:9757-9762[Abstract/Free Full Text].
|
| 18.
|
Drummond, J. T.,
A. Anthoney,
R. Brown, and P. Modrich.
1996.
Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line.
J. Biol. Chem.
271:19645-19648[Abstract/Free Full Text].
|
| 19.
|
Drummond, J. T.,
G.-M. Li,
M. J. Longley, and P. Modrich.
1995.
Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.
Science
268:1909-1912[Abstract/Free Full Text].
|
| 20.
|
Dutta, I., and I. Inouye.
2000.
GHKL, an emergent ATPase/kinase superfamily.
Trends Biochem. Sci.
25:24-28[CrossRef][Medline].
|
| 21.
|
Fishel, R. A.,
M. K. Lescoe,
M. R. S. Rao,
N. Copeland,
N. Jenkins,
J. Garber,
M. Kane, and R. Kolodner.
1993.
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
Cell
75:1027-1038[CrossRef][Medline].
|
| 22.
|
Flores-Rozas, H., and R. D. Kolodner.
1998.
The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations.
Proc. Natl. Acad. Sci. USA
95:12404-12409[Abstract/Free Full Text].
|
| 23.
|
Genschel, J.,
S. J. Littman,
J. T. Drummond, and P. Modrich.
1998.
Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.
J. Biol. Chem.
273:19895-19901[Abstract/Free Full Text].
|
| 24.
|
Gietz, R. D., and R. H. Schiestl.
1991.
Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier.
Yeast
7:253-263[CrossRef][Medline].
|
| 25.
|
Grenert, J. P.,
B. D. Johnson, and D. O. Toft.
1999.
The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes.
J. Biol. Chem.
274:17525-17533[Abstract/Free Full Text].
|
| 26.
|
Grenert, J. P.,
W. P. Sullivan,
P. Fadden,
T. A. J. Haystead,
J. Clark,
E. Mimnaugh,
H. Krutzsch,
H. J. Ochel,
T. W. Schulte,
E. Sausville,
L. M. Neckers, and D. O. Toft.
1997.
The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation.
J. Biol. Chem.
272:23843-23850[Abstract/Free Full Text].
|
| 27.
|
Habraken, Y.,
P. Sung,
L. Prakash, and S. Prakash.
1997.
Enhancement of MSH2-MSH3-mediated mismatch recognition by the yeast MLH1-PMS1 complex.
Curr. Biol.
7:790-793[CrossRef][Medline].
|
| 28.
|
Harkins, T. T.,
T. J. Lewis, and J. E. Lindsley.
1998.
Pre-steady-state analysis of ATP hydrolysis by Saccharomyces cerevisiae DNA topoisomerase II. 2. Kinetic mechanism for the sequential hydrolysis of two ATP.
Biochemistry
37:7299-7312[CrossRef][Medline].
|
| 29.
|
Hingorani, M. M.,
L. B. Bloom,
M. F. Goodman, and M. O'Donnell.
1999.
Division of labor sequential ATP hydrolysis drives assembly of a DNA polymerase sliding clamp around DNA.
EMBO J.
18:5131-5144[CrossRef][Medline].
|
| 30.
|
Hunter, N., and R. H. Borts.
1997.
Mlh1 is unique among mismatch repair proteins in its ability to promote crossing-over during meiosis.
Genes Dev.
11:1573-1582[Abstract/Free Full Text].
|
| 31.
|
Hunter, N.,
S. R. Chambers,
E. J. Louis, and R. H. Borts.
1996.
The mismatch repair system contributes to meiotic sterility in an interspecific yeast hybrid.
EMBO J.
15:1726-1733[Medline].
|
| 32.
|
Iaccarino, I.,
G. Marra,
F. Palombo, and J. Jiricny.
1998.
hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha.
EMBO J.
17:2677-2686[CrossRef][Medline].
|
| 33.
|
Iaccarino, I.,
F. Palombo,
J. Drummond,
N. F. Totty,
J. J. Hsuan,
P. Modrich, and J. Jiricny.
1996.
MSH6, a Saccharomyces cerevisiae protein that binds to mismatches as a heterodimer with MSH2.
Curr. Biol.
6:484-486[CrossRef][Medline].
|
| 34.
|
Jackson, A. P., and A. Maxwell.
1993.
Identifying the catalytic residue of the ATPase reaction of DNA gyrase.
Proc. Natl. Acad. Sci. USA
90:11232-11236[Abstract/Free Full Text].
|
| 35.
|
Jakob, U.,
T. Scheibel,
S. Bose,
J. Reinstein, and J. Buchner.
1996.
Assessment of the ATP binding properties of Hsp90.
J. Biol. Chem.
271:10035-10041[Abstract/Free Full Text].
|
| 36.
|
Jiricny, J.
1998.
Eukaryotic mismatch repair: an update.
Mutat. Res.
409:107-121[Medline].
|
| 37.
|
Johnson, R. E.,
G. K. Kovvali,
L. Prakash, and S. Prakash.
1996.
Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.
J. Biol. Chem.
271:7285-7288[Abstract/Free Full Text].
|
| 38.
|
Kolodner, R. D., and G. T. Marsischky.
1999.
Eukaryotic DNA mismatch repair.
Curr. Opin. Genet. Dev.
9:89-96[CrossRef][Medline].
|
| 39.
|
Leach, F. S.,
N. C. Nicolaides,
N. Papadopoulos,
B. Liu,
J. Jen,
R. Parsons,
P. Peltomaki,
P. Sistonen,
L. A. Aaltonen,
M. Nystrom-Lahti,
X.-Y. Guan,
J. Zhang,
P. S. Meltzer,
J.-W. Yu,
F.-T. Kao,
D. J. Chen,
K. M. Cerosaletti,
R. E. K. Fournier,
S. Todd,
T. Lewis,
R. J. Leach,
S. L. Naylor,
J. Weissenbach,
J.-P. Mecklin,
H. Jarvinen,
G. M. Petersen,
S. R. Hamilton,
J. Green,
J. Jass,
P. Watson,
H. T. Lynch,
J. M. Trent,
A. de la Chapelle,
K. W. Kinzler, and B. Vogelstein.
1993.
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
Cell
75:1215-1225[CrossRef][Medline].
|
| 40.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 41.
|
Marsischky, G. T.,
M. Filosi,
M. F. Kane, and R. Kolodner.
1996.
Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.
Genes Dev.
10:407-420[Abstract/Free Full Text].
|
| 42.
|
Marsischky, G. T., and R. D. Kolodner.
1999.
Biochemical characterization of the interaction between the Saccharomyces cerevisiae MSH2-MSH6 complex and mispaired bases in DNA.
J. Biol. Chem.
274:26668-26682[Abstract/Free Full Text].
|
| 43.
|
Modrich, P., and R. Lahue.
1996.
Mismatch repair in replication fidelity, genetic recombination, and cancer biology.
Annu. Rev. Biochem.
65:101-133[CrossRef][Medline].
|
| 44.
|
Mushegian, A. R.,
D. E. Bassett, Jr.,
M. S. Boguski,
P. Bork, and E. V. Koonin.
1997.
Positionally cloned human disease genes: patterns of evolutionary conservation and functional motifs.
Proc. Natl. Acad. Sci. USA
94:5831-5836[Abstract/Free Full Text].
|
| 45.
|
New, L.,
K. Liu, and G. F. Crouse.
1993.
The yeast gene MSH3 defines a new class of eukaryotic MutS homologues.
Mol. Gen. Genet.
239:97-108[CrossRef][Medline].
|
| 46.
|
Nicolaides, N. C.,
S. J. Littman,
P. Modrich,
K. W. Kinzler, and B. Vogelstein.
1998.
A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype.
Mol. Cell. Biol.
18:1635-1641[Abstract/Free Full Text].
|
| 47.
|
Obermann, W. M. J.,
H. Sondermann,
A. A. Russo,
N. P. Pavletich, and F. U. Hartl.
1998.
In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis.
J. Cell Biol.
143:901-910[Abstract/Free Full Text].
|
| 48.
|
Palombo, F.,
P. Gallinari,
I. Iaccarino,
T. Lettier,
M. Hughes,
A. D'Arrigo,
O. Truong,
J. J. Hsuan, and J. Jiricny.
1995.
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.
Science
268:1912-1914[Abstract/Free Full Text].
|
| 49.
|
Palombo, F.,
I. Iaccarino,
E. Nakajima,
M. Ikejima,
T. Shimada, and J. Jiricny.
1996.
hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA.
Curr. Biol.
6:1181-1184[CrossRef][Medline].
|
| 50.
|
Panaretou, B.,
C. Prodromou,
S. M. Roe,
R. O'Brien,
J. E. Ladbury,
P. W. Piper, and L. H. Pearl.
1998.
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo.
EMBO J.
17:4829-4836[CrossRef][Medline].
|
| 51.
|
Pang, Q.,
T. A. Prolla, and R. M. Liskay.
1997.
Functional domains of the Saccharomyces cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance to hereditary nonpolyposis colorectal cancer-associated mutations.
Mol. Cell. Biol.
17:4465-4473[Abstract].
|
| 52.
|
Papadopoulos, N.,
N. C. Nicolaides,
Y.-F. Wei,
S. M. Ruben,
K. C. Carter,
C. A. Rosen,
W. A. Haseltine,
R. D. Fleischmann,
C. M. Fraser,
M. D. Adams,
J. C. Venter,
S. R. Hamilton,
G. M. Petersen,
P. Watson,
H. T. Lynch,
P. Peltomaki,
J.-P. Mecklin,
A. de la Chapelle,
K. W. Kinzler, and B. Vogelstein.
1994.
Mutation of a mutL homolog in hereditary colon cancer.
Science
263:1625-1629[Abstract/Free Full Text].
|
| 53.
|
Petes, T. D.,
R. E. Malone, and L. S. Symington.
1991.
Recombination in yeast, p. 407-521.
In
J. Broach, E. Jones, and J. Pringle (ed.), The molecular and cellular biology of the yeast Saccharomyces, vol. 1. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 54.
|
Printen, J. A., and G. F. Sprague, Jr.
1994.
Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade.
Genetics
138:609-619[Abstract].
|
| 55.
|
Prodromou, C.,
S. M. Roe,
R. O'Brien,
J. E. Ladbury,
P. W. Piper, and L. H. Pearl.
1997.
Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone.
Cell
90:65-75[CrossRef][Medline].
|
| 56.
|
Prodromou, C.,
S. M. Roe,
P. W. Piper, and L. H. Pearl.
1997.
A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone.
Nat. Struct. Biol.
4:477-482[CrossRef][Medline].
|
| 57.
|
Prodromou, C.,
G. Siligardi,
R. O'Brien,
D. N. Woolfson,
L. Regan,
B. Panaretou,
J. E. Ladbury,
P. W. Piper, and L. H. Pearl.
1999.
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones.
EMBO J.
18:754-762[CrossRef][Medline].
|
| 58.
|
Prolla, T. A.,
D.-M. Christie, and R. M. Liskay.
1994.
Dual requirement in yeast DNA mismatch repair for MLH1 and PMS1, two homologs of the bacterial mutL gene.
Mol. Cell. Biol.
14:407-415[Abstract/Free Full Text].
|
| 59.
|
Prolla, T. A.,
Q. Pang,
E. Alani,
R. D. Kolodner, and R. M. Liskay.
1994.
Interactions between the Msh2, Mlh1 and Pms1 proteins during the initiation of DNA mismatch repair.
Science
265:1091-1093[Abstract/Free Full Text].
|
| 60.
|
Sancar, A., and J. E. Hearst.
1993.
Molecular matchmakers.
Science
259:1415-1420[Abstract/Free Full Text].
|
| 61.
|
Scheibel, T.,
S. Neuhofen,
T. Weikl,
C. Mayr,
J. Reinstein,
P. D. Vogel, and J. Buchner.
1997.
ATP-binding properties of human Hsp90.
J. Biol. Chem.
272:18608-18613[Abstract/Free Full Text].
|
| 62.
|
Selva, E. M.,
L. New,
G. F. Crouse, and R. S. Lahue.
1995.
Mismatch correction acts as a barrier to homeologous recombination in Saccharomyces cerevisiae.
Genetics
139:1175-1188[Abstract].
|
| 63.
|
Shcherbakova, P. V., and T. A. Kunkel.
1999.
Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations.
Mol. Cell. Biol.
19:3177-3183[Abstract/Free Full Text].
|
| 64.
|
Studamire, B.,
T. Quach, and E. Alani.
1998.
Saccharomyces cerevisiae Msh2p and Msh6p ATPase activities are both required during mismatch repair.
Mol. Cell. Biol.
18:7590-7601[Abstract/Free Full Text].
|
| 65.
|
Sugino, A., and N. R. Cozzarelli.
1980.
The intrinsic ATPase of DNA gyrase.
J. Biol. Chem.
255:6299-6306[Free Full Text].
|
| 66.
|
Tishkoff, D. X.,
N. Filosi,
G. M. Gaida, and R. D. Kolodner.
1997.
A novel mutation avoidance mechanism dependent on S. cerevisiae RAD27 is distinct from DNA mismatch repair.
Cell
88:253-263[CrossRef][Medline].
|
| 67.
|
Umar, A.,
A. B. Buermeyer,
J. A. Simon,
D. C. Thomas,
A. B. Clark,
R. M. Liskay, and T. A. Kunkel.
1996.
Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis.
Cell
87:65-73[CrossRef][Medline].
|
| 68.
|
Viswanathan, M., and S. T. Lovett.
1998.
Single-strand DNA-specific exonucleases in Escherichia coli. Roles in repair and mutation avoidance.
Genetics
149:7-16[Abstract/Free Full Text].
|
| 69.
|
Vojtek, A. B.,
S. M. Hollenberg, and J. A. Cooper.
1993.
Mammalian ras interacts directly with the serine/threonine kinase raf.
Cell
74:205-214[CrossRef][Medline].
|
| 70.
|
Wang, T. F.,
N. Kleckner, and N. Hunter.
1999.
Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction.
Proc. Natl. Acad. Sci. USA
96:13914-13919[Abstract/Free Full Text].
|
| 71.
|
Wigley, D. B.,
G. J. Davies,
E. J. Dodson,
A. Maxwell, and G. Dodson.
1991.
Crystal structure of an N-terminal fragment of the DNA gyrase B protein.
Nature
351:624-629[CrossRef][Medline].
|
Molecular and Cellular Biology, September 2000, p. 6390-6398, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dherin, C., Gueneau, E., Francin, M., Nunez, M., Miron, S., Liberti, S. E., Rasmussen, L. J., Zinn-Justin, S., Gilquin, B., Charbonnier, J.-B., Boiteux, S.
(2009). Characterization of a Highly Conserved Binding Site of Mlh1 Required for Exonuclease I-Dependent Mismatch Repair. Mol. Cell. Biol.
29: 907-918
[Abstract]
[Full Text]
-
Wanat, J. J., Singh, N., Alani, E.
(2007). The effect of genetic background on the function of Saccharomyces cerevisiae mlh1 alleles that correspond to HNPCC missense mutations. Hum Mol Genet
16: 445-452
[Abstract]
[Full Text]
-
Erdeniz, N., Dudley, S., Gealy, R., Jinks-Robertson, S., Liskay, R. M.
(2005). Novel PMS1 Alleles Preferentially Affect the Repair of Primer Strand Loops during DNA Replication. Mol. Cell. Biol.
25: 9221-9231
[Abstract]
[Full Text]
-
Mendillo, M. L., Mazur, D. J., Kolodner, R. D.
(2005). Analysis of the Interaction between the Saccharomyces cerevisiae MSH2-MSH6 and MLH1-PMS1 Complexes with DNA Using a Reversible DNA End-blocking System. J. Biol. Chem.
280: 22245-22257
[Abstract]
[Full Text]
-
Fearnhead, N. S., Wilding, J. L., Winney, B., Tonks, S., Bartlett, S., Bicknell, D. C., Tomlinson, I. P. M., Mortensen, N. J. McC., Bodmer, W. F.
(2004). Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl. Acad. Sci. USA
101: 15992-15997
[Abstract]
[Full Text]
-
Ellison, A. R., Lofing, J., Bitter, G. A.
(2004). Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res
32: 5321-5338
[Abstract]
[Full Text]
-
Shaver, A. C., Sniegowski, P. D.
(2003). Spontaneously Arising mutL Mutators in Evolving Escherichia coli Populations Are the Result of Changes in Repeat Length. J. Bacteriol.
185: 6076-6082
[Abstract]
[Full Text]
-
Plotz, G., Raedle, J., Brieger, A., Trojan, J., Zeuzem, S.
(2003). N-terminus of hMLH1 confers interaction of hMutL{alpha} and hMutL{beta} with hMutS{alpha}. Nucleic Acids Res
31: 3217-3226
[Abstract]
[Full Text]
-
Wu, X., Platt, J. L., Cascalho, M.
(2003). Dimerization of MLH1 and PMS2 Limits Nuclear Localization of MutL{alpha}. Mol. Cell. Biol.
23: 3320-3328
[Abstract]
[Full Text]
-
Hall, M. C., Shcherbakova, P. V., Fortune, J. M., Borchers, C. H., Dial, J. M., Tomer, K. B., Kunkel, T. A.
(2003). DNA binding by yeast Mlh1 and Pms1: implications for DNA mismatch repair. Nucleic Acids Res
31: 2025-2034
[Abstract]
[Full Text]
-
Argueso, J. L., Kijas, A. W., Sarin, S., Heck, J., Waase, M., Alani, E.
(2003). Systematic Mutagenesis of the Saccharomyces cerevisiae MLH1 Gene Reveals Distinct Roles for Mlh1p in Meiotic Crossing Over and in Vegetative and Meiotic Mismatch Repair. Mol. Cell. Biol.
23: 873-886
[Abstract]
[Full Text]
-
Hoffmann, E. R., Shcherbakova, P. V., Kunkel, T. A., Borts, R. H.
(2003). MLH1 Mutations Differentially Affect Meiotic Functions in Saccharomyces cerevisiae. Genetics
163: 515-526
[Abstract]
[Full Text]
-
Welz-Voegele, C., Stone, J. E., Tran, P. T., Kearney, H. M., Liskay, R. M., Petes, T. D., Jinks-Robertson, S.
(2002). Alleles of the Yeast PMS1 Mismatch-Repair Gene That Differentially Affect Recombination- and Replication-Related Processes. Genetics
162: 1131-1145
[Abstract]
[Full Text]
-
Shaver, A. C., Dombrowski, P. G., Sweeney, J. Y., Treis, T., Zappala, R. M., Sniegowski, P. D.
(2002). Fitness Evolution and the Rise of Mutator Alleles in Experimental Escherichia coli Populations. Genetics
162: 557-566
[Abstract]
[Full Text]
-
Tomer, G., Buermeyer, A. B., Nguyen, M. M., Liskay, R. M.
(2002). Contribution of Human Mlh1 and Pms2 ATPase Activities to DNA Mismatch Repair. J. Biol. Chem.
277: 21801-21809
[Abstract]
[Full Text]
-
Raschle, M., Dufner, P., Marra, G., Jiricny, J.
(2002). Mutations within the hMLH1 and hPMS2 Subunits of the Human MutLalpha Mismatch Repair Factor Affect Its ATPase Activity, but Not Its Ability to Interact with hMutSalpha. J. Biol. Chem.
277: 21810-21820
[Abstract]
[Full Text]
-
Argueso, J. L., Smith, D., Yi, J., Waase, M., Sarin, S., Alani, E.
(2002). Analysis of Conditional Mutations in the Saccharomyces cerevisiae MLH1 Gene in Mismatch Repair and in Meiotic Crossing Over. Genetics
160: 909-921
[Abstract]
[Full Text]
-
Owen, B. A. L., Sullivan, W. P., Felts, S. J., Toft, D. O.
(2002). Regulation of Heat Shock Protein 90 ATPase Activity by Sequences in the Carboxyl Terminus. J. Biol. Chem.
277: 7086-7091
[Abstract]
[Full Text]
-
Hall, M. C., Shcherbakova, P. V., Kunkel, T. A.
(2002). Differential ATP Binding and Intrinsic ATP Hydrolysis by Amino-terminal Domains of the Yeast Mlh1 and Pms1 Proteins. J. Biol. Chem.
277: 3673-3679
[Abstract]
[Full Text]
-
Sia, E. A., Dominska, M., Stefanovic, L., Petes, T. D.
(2001). Isolation and Characterization of Point Mutations in Mismatch Repair Genes That Destabilize Microsatellites in Yeast. Mol. Cell. Biol.
21: 8157-8167
[Abstract]
[Full Text]
-
Ellison, A. R., Lofing, J., Bitter, G. A.
(2001). Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet
10: 1889-1900
[Abstract]
[Full Text]
-
Amin, N. S., Nguyen, M.-N., Oh, S., Kolodner, R. D.
(2001). exo1-Dependent Mutator Mutations: Model System for Studying Functional Interactions in Mismatch Repair. Mol. Cell. Biol.
21: 5142-5155
[Abstract]
[Full Text]
-
Tran, P. T., Simon, J. A., Liskay, R. M.
(2001). Interactions of Exo1p with components of MutLalpha in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA
10.1073/pnas.161175998v1
[Abstract]
[Full Text]
-
Schmutte, C., Sadoff, M. M., Shim, K.-S., Acharya, S., Fishel, R.
(2001). The Interaction of DNA Mismatch Repair Proteins with Human Exonuclease I. J. Biol. Chem.
276: 33011-33018
[Abstract]
[Full Text]
-
Tran, P. T., Simon, J. A., Liskay, R. M.
(2001). Interactions of Exo1p with components of MutLalpha in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA
98: 9760-9765
[Abstract]
[Full Text]